COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 349: Articles 3481-3490  | Next

Real-time epidemiological modelling during the COVID-19 emergency in Wales
Gravenor, M., Dawson, M., Bennett, E., Thorpe, B., White, C., Rahat, A., Archambault, D., Picco, N., Powathil, G., Lucini, B.
10.1101/2023.08.02.23293519 — Posted: 2023-08-04
Text mining biomedical literature to identify extremely unbalanced data for digital epidemiology and systematic reviews: dataset and methods for a SARS-CoV-2 genomic epidemiology study
Weissenbacher, D., O'COnnor, K., Klein, A., Golder, S., Flores Amaro, I., Elyaderani, A., Scotch, M., Gonzalez-Hernandez, G.
10.1101/2023.07.29.23293370 — Posted: 2023-08-04
Predicting Long COVID in the National COVID Cohort Collaborative Using Super Learner
Butzin-Dozier, Z., Ji, Y., Li, H., Coyle, J., Shi, J., Phillips, R. V., Mertens, A., Pirracchio, R., van der Laan, M. J., Patel, R. C., Colford, J. M., Hubbard, A. E., on behalf of the National COVID Cohort Collaborative (N3C) Consortium*
10.1101/2023.07.27.23293272 — Posted: 2023-08-04
Bi-directional associations between mask usage and the associated reasons before and after the downgrading of the legal status of COVID-19 in Japan: A longitudinal study
Murakami, M.
10.1101/2023.07.28.23293298 — Posted: 2023-08-04
Exploring Disparities and Novel Insights into Metabo-Nutritional Comorbidities among COVID-19 Patients in Mexico
Lopez-Cuevas, A., Martinez-Garcia, M., Hernandez-Lemus, E., de Anda-Jauregui, G.
10.1101/2023.07.31.23293471 — Posted: 2023-08-04
The Lancet peer reviewers and the COVID-19 pandemic
Masukume, G., Grech, V.
10.1101/2023.08.02.23293558 — Posted: 2023-08-04
Comparing full variation profile analysis with the conventional consensus method in SARS-CoV-2 phylogeny
Fiam, R. N., Csabai, I., Solymosi, N.
10.1101/2023.08.03.551784 — Posted: 2023-08-04
Single-linkage molecular clustering of viral pathogens
Soto Miranda, M., Narvaez Romo, R., Moshiri, N.
10.1101/2023.08.03.551813 — Posted: 2023-08-04
Neutralizing antibody responses and cellular responses against severe acute respiratory syndrome coronavirus 2 omicron subvariant BA.5 after an mRNA severe acute respiratory syndrome coronavirus 2 vaccine dose in kidney transplant recipients
Kawashiro, K., Suzuki, R., Nogimori, T., Iwahara, N., Hirose, T., Okada, K., Yamamoto, T., Fukuhara, T., Hotta, K., Shinohara, N.
10.1101/2023.08.02.551424 — Posted: 2023-08-03
Tetherin restricts SARS-CoV-2 replication despite antagonistic effects of Spike and ORF7a
Hagelauer, E., Lotke, R., Kmiec, D., Hu, D., Hohner, M., Stopper, S., Layer, M., Nchioua, R., Kirchhoff, F., Sauter, D., Schindler, M.
10.1101/2023.07.28.550997 — Posted: 2023-08-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).